Stock Losers: Generex Biotechnology Corporation, Manulife Financial

Stock Losers: Generex Biotechnology Corporation, Manulife Financial
Generex Biotechnology Corporation (PINK: GNBT) increased 4.04% and closed at $ 0.0309 on a traded volume of 1.10 million shares. So far this year, the stock is up over 29%. The 52-week range for the stock is $ 0.02 and $ 0.13. Generex Biotechnology …
Read more on SBWire (press release)

BIL Gates And The BioBrick Foundation: A New Paradigm For Biotechnology?
No, that's not a typo in the headline. I'm not talking about the founder of Microsoft, though he is no doubt the reason that biotechnology researcher Drew Endy decided to name his new computer-in-a-cell devices Boolean Integrase Logic gates (BIL for …

How to Talk About Biotechnology
It's been said before, but it bears repeating that genetic modification is little more than a new tool in the perennial human endeavor to modify the biology that surrounds us – a project that exploded with the advent of agriculture and the development …
Read more on Discover Magazine (blog)

This entry was posted in Biotechnology and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply